Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | ACLX | MLTX | ||
| Company | Morphosys Ag ADR | Arcellx Inc | Moonlake Immunotherapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 17.99 | 52.25 | 41.48 | ||
| High | 18.09 | 55.94 | 43.26 | ||
| Low | 17.95 | 52.25 | 41.45 | ||
| Last | 18.04 | 54.44 | 43.25 | ||
| Change | +0.08 | +2.44 | +2.23 | ||
| % Change | +0.45% | +4.69% | +5.44% | ||
| Volume | 181,700 | 408,900 | 579,300 | ||
| 20-Day Average Volume | 359,785 | 455,450 | 417,150 | ||
| Previous Close | 17.96 | 52.00 | 41.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.07 | 60.29 | 45.68 | ||
| 20-Day Raw Stochastic | 51.52% | 18.71% | 20.53% | ||
| 20-Day Relative Strength | 63.70% | 37.91% | 40.18% | ||
| Weighted Alpha | +79.61 | +9.04 | +7.10 | ||
| Today's Opinion | 88% Buy | 8% Buy | 100% Sell | ||
| Previous Opinion | 88% Buy | 8% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.50% since 04/16/24 | -1.41% since 04/16/24 | -0.57% since 04/16/24 | ||
| Low | 17.90 on 04/22/24 | 50.54 on 04/22/24 | 40.68 on 04/19/24 | ||
| High | 18.09 on 04/23/24 | 55.94 on 04/23/24 | 43.88 on 04/17/24 | ||
| 1-Month | |||||
| %Chg | -0.77% since 03/22/24 | -22.48% since 03/22/24 | -16.83% since 03/22/24 | ||
| Low | 17.87 on 04/03/24 | 50.54 on 04/22/24 | 40.68 on 04/19/24 | ||
| High | 18.22 on 03/25/24 | 71.81 on 03/25/24 | 53.99 on 03/25/24 | ||
| 3-Month | |||||
| %Chg | +97.81% since 01/23/24 | -2.92% since 01/23/24 | -23.42% since 01/23/24 | ||
| Low | 9.42 on 01/24/24 | 50.54 on 04/22/24 | 40.68 on 04/19/24 | ||
| High | 18.31 on 03/12/24 | 75.10 on 03/07/24 | 64.98 on 02/12/24 | ||
| 6-Month | |||||
| %Chg | +164.13% since 10/23/23 | +68.13% since 10/23/23 | -18.57% since 10/23/23 | ||
| Low | 4.18 on 11/22/23 | 30.88 on 10/27/23 | 35.11 on 11/06/23 | ||
| High | 18.31 on 03/12/24 | 75.10 on 03/07/24 | 64.98 on 02/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,705,153 | 2,771,080 | 2,620,645 | ||
| Shares Outstanding, K | 150,621 | 53,290 | 63,887 | ||
| Annual Sales | 257,890,000 | 110,320,000 | 0 | ||
| Annual Net Income | -205,350,000 | -70,690,000 | -36,010,000 | ||
| Last Quarter Sales | 63,610,000 | 63,150,000 | 0 | ||
| Last Quarter Net Income | 53,170,000 | 19,840,000 | -5,330,000 | ||
| 60-Month Beta | 1.17 | 0.02 | 1.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 03/13/24 | 0.42 on 02/28/24 | -0.12 on 02/29/24 | ||
| Latest Earnings Date | 05/01/24 | 05/13/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||